Skip to main content
CVE-2026-56207VulnerabilityPublished 09/09/2026Updated 09/10/2026

CVE-2026-56207: CWE-347 Improper Verification of Cryptographic Signature in Apache Software Foundation Apache Impala

Affects Apache Software Foundation Apache ImpalaSource CVE Database V5

0

Not known to be exploited · CVSS 9.8 Critical · fixed in 4.5.2 : patch Apache Software Foundation Apache Impala as a priority.

Data as of 10/25/2026, 04:40:13 UTC

CVSS 3.1 base score
9.8Critical
How severe the flaw is on the 0–10 CVSS scale.
Exploitation

Not in CISA KEV, no exploitation reported

EPSS
0.4% chance of exploitation in 30 days – higher than 39% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available – fixed in 4.5.2
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

What to do

Affected software

ProductAffectedFixed in
Apache Software FoundationApache ImpalaAffected
  • >=4.0.0 <=4.5.1
Fixed in–
Mavenorg.apache.impala/impalapkg:maven/org.apache.impala/impalaOther threatsAffected
  • =4.0.0
  • >=4.0.0 <4.5.2
  • =4.0.0
Fixed in
  • 4.5.2

Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.

AI-suggested

Users should upgrade Apache Impala to version 4.5.2 or later, where this vulnerability is fixed. No other mitigations are specified. Patch status is confirmed by the vendor advisory recommending upgrade to 4.5.2.

Description

CVE-2026-56207 is a critical vulnerability in Apache Impala versions 4.0.0 through 4.5.1 where the signature of the Bearer token is not verified in the final step of SAML2 authentication for the hs2-http interface. This flaw allows an attacker to alter the user name and impersonate another user. The issue is fixed in version 4.5.2.

Impact

Successful exploitation allows an unauthenticated attacker to impersonate any user by altering the Bearer token's user name during SAML2 authentication. This results in full confidentiality, integrity, and availability impact on the affected system, as indicated by the CVSS score of 9.8 (critical).

Weaknesses

References

Community reviews

Loading reviews…